Similar results have been reported by researchers who studied the effect of gene therapy with the use of CD40L on gastric cancers [94], non-small-cell lung cancer [95], breast cancer [85], cancers of the uterine cervix, and the prostate [96]. Here, CD40LG is linked to gastric cancer.